1. Home
  2. EVGN vs XYLO Comparison

EVGN vs XYLO Comparison

Compare EVGN & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • XYLO
  • Stock Information
  • Founded
  • EVGN 1999
  • XYLO 1999
  • Country
  • EVGN Israel
  • XYLO Israel
  • Employees
  • EVGN 75
  • XYLO N/A
  • Industry
  • EVGN Agricultural Chemicals
  • XYLO
  • Sector
  • EVGN Industrials
  • XYLO
  • Exchange
  • EVGN Nasdaq
  • XYLO NYSE
  • Market Cap
  • EVGN 11.3M
  • XYLO 6.5M
  • IPO Year
  • EVGN N/A
  • XYLO N/A
  • Fundamental
  • Price
  • EVGN $1.33
  • XYLO N/A
  • Analyst Decision
  • EVGN Strong Buy
  • XYLO
  • Analyst Count
  • EVGN 1
  • XYLO 0
  • Target Price
  • EVGN $3.50
  • XYLO N/A
  • AVG Volume (30 Days)
  • EVGN 5.5M
  • XYLO 2.9K
  • Earning Date
  • EVGN 08-21-2025
  • XYLO 07-15-2025
  • Dividend Yield
  • EVGN N/A
  • XYLO N/A
  • EPS Growth
  • EVGN N/A
  • XYLO N/A
  • EPS
  • EVGN N/A
  • XYLO N/A
  • Revenue
  • EVGN $6,765,000.00
  • XYLO $29,858,000.00
  • Revenue This Year
  • EVGN N/A
  • XYLO $279.19
  • Revenue Next Year
  • EVGN $113.18
  • XYLO N/A
  • P/E Ratio
  • EVGN N/A
  • XYLO N/A
  • Revenue Growth
  • EVGN N/A
  • XYLO N/A
  • 52 Week Low
  • EVGN $0.95
  • XYLO $2.70
  • 52 Week High
  • EVGN $6.80
  • XYLO $6.67
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 49.73
  • XYLO 49.56
  • Support Level
  • EVGN $1.26
  • XYLO $4.92
  • Resistance Level
  • EVGN $1.44
  • XYLO $5.10
  • Average True Range (ATR)
  • EVGN 0.11
  • XYLO 0.15
  • MACD
  • EVGN -0.02
  • XYLO 0.00
  • Stochastic Oscillator
  • EVGN 21.62
  • XYLO 65.79

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.

Share on Social Networks: